ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,132.80
      -0.52%
      Dow Jones
      39,065.26
      -1.53%
      Brent Oil
      81.27
      -0.32%
      Bitcoin
      67,932.86
      -1.72%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      Symbol: 
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      05/23/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MCKMcKesson Corporation
      05/23/20245:02PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
      05/23/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MCKMcKesson Corporation
      05/23/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XELXcel Energy Inc
      05/23/20245:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPRTCopart Inc
      05/23/20245:02PMBusiness WireKBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
      05/23/20245:02PMBusiness WireStellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase ProgramNYSE:STELStellar Bancorp Inc
      05/23/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MCKMcKesson Corporation
      05/23/20245:01PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BACBank of America Corporation
      05/23/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MCKMcKesson Corporation
      05/23/20245:01PMGlobeNewswire Inc.Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:ZNTLZentalis Pharmaceuticals Inc
      05/23/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NSPInsperity Inc
      05/23/20245:01PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BMOBank of Montreal
      05/23/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MCKMcKesson Corporation
      05/23/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STELStellar Bancorp Inc
      05/23/20245:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CINGWCingulate Inc
      05/23/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:WEAVWeave Communications Inc
      05/23/20245:01PMBusiness WireNMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
      05/23/20245:01PMBusiness WireVerastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer​NASDAQ:VSTMVerastem Inc
      05/23/20245:01PMGlobeNewswire Inc.HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual MeetingNASDAQ:HOOKHOOKIPA Pharma Inc
      05/23/20245:01PMGlobeNewswire Inc.Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual MeetingNASDAQ:COGTCogent Biosciences Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRMSalesforce Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:MCKMcKesson Corporation
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:KNTKKinetik Holdings Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGYSAgilysys Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:YUMCYum China Holdings Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEDSTRxADE HEALTH Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
      05/23/20245:00PMGlobeNewswire Inc.Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual CongressNASDAQ:ARVNArvinas Inc